UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Final overall survival results of WJTOG3405, a randomized phase III trial comparing gefitinib versus cisplatin with docetaxel as the first-line treatment for patients with stage IIIB/IV or postoperative recurrent EGFR mutation-positive non-small-cell lung cancer

Annals of oncology, 2019-12, Vol.30 (12), p.1978-1984

2019

Volltextzugriff (PDF)

A randomized, double-blind, placebo-controlled, phase III trial of erlotinib with or without a c-Met inhibitor tivantinib (ARQ 197) in Asian patients with previously treated stage IIIB/IV nonsquamous nonsmall-cell lung cancer harboring wild-type epidermal growth factor receptor (ATTENTION study)

Annals of oncology, 2015-10, Vol.26 (10), p.2066-2072

2015

Volltextzugriff (PDF)

Multicentre prospective phase II trial of gefitinib for advanced non-small cell lung cancer with epidermal growth factor receptor mutations: results of the West Japan Thoracic Oncology Group trial (WJTOG0403)

British journal of cancer, 2008-03, Vol.98 (5), p.907-914

2008

Volltextzugriff (PDF)

NUMERICAL ANALYSIS OF LOAD‐BEARING FIRE TEST FOR REINFORCED CONCRETE SLABS

ce/papers, 2023-02, Vol.6 (1), p.411-422

2023

Volltextzugriff (PDF)

The effect of CYP2C19 polymorphism on the safety, tolerability, and pharmacokinetics of tivantinib (ARQ 197): results from a phase I trial in advanced solid tumors

Annals of oncology, 2013-06, Vol.24 (6), p.1653-1659

2013

Volltextzugriff (PDF)

Efficacy and safety analysis according to histology for S-1 in combination with carboplatin as first-line chemotherapy in patients with advanced non-small-cell lung cancer: updated results of the West Japan Oncology Group LETS study

Annals of oncology, 2013-05, Vol.24 (5), p.1326-1331

2013

Volltextzugriff (PDF)

Which of afatinib and gefitinib/erlotinib is the better EGFR-TKI to be followed by osimertinib?

Annals of oncology, 2018-10, Vol.29, p.viii527-viii528

2018

Volltextzugriff (PDF)

Investigation of learning environment for arithmetic word problems by problem posing as sentence integration in Indonesian language

Journal of physics. Conference series, 2017-02, Vol.812 (1), p.12060

2017

Volltextzugriff (PDF)

Process-based Assignment-Setting Change for Support of Overcoming Bottlenecks in Learning by Problem-Posing in Arithmetic Word Problems

Journal of physics. Conference series, 2017-02, Vol.812 (1), p.12004

2017

Volltextzugriff (PDF)

Dose escalation study of carboplatin–pemetrexed followed by maintenance pemetrexed for elderly patients with advanced nonsquamous nonsmall-cell lung cancer

Annals of oncology, 2013-04, Vol.24 (4), p.980-985

2013

Volltextzugriff (PDF)

CYP2C19 genotype-based phase I studies of a c-Met inhibitor tivantinib in combination with erlotinib, in advanced/metastatic non-small cell lung cancer

British journal of cancer, 2013-11, Vol.109 (11), p.2803-2809

2013

Volltextzugriff (PDF)

Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain

Diabetes (New York, N.Y.), 1992-11, Vol.41 (11), p.1422-1428

1992

Volltextzugriff (PDF)

3078 Updated results and efficacy analysis according to epidermal growth factor receptor (EGFR) mutation subtypes and metastatic sites for the phase II trial of gefitinib in combination with carboplatin plus S1

European journal of cancer (1990), 2015-09, Vol.51, p.S623-S623

2015

Volltextzugriff (PDF)

1325 A phase II study of pemetrexed plus carboplatin followed by maintenance pemetrexed as first-line chemotherapy for elderly patients (75-years-old) with advanced non-squamous, non-small cell lung cancer

European journal of cancer (1990), 2015-09, Vol.51, p.S196-S196

2015

Volltextzugriff (PDF)

3083 AZD9291 activity in patients with EGFR-mutant advanced non-small cell lung cancer (NSCLC) and brain metastases: Data from Phase II studies

European journal of cancer (1990), 2015-09, Vol.51, p.S625-S626

2015

Volltextzugriff (PDF)

521 Phase II studies of Nivolumab in patients with Advanced Squamous (SQ) or Non-Squamous (NSQ) Non-Small Cell Lung Cancer (NSCLC)

European journal of cancer (1990), 2015-09, Vol.51, p.S110-S111

2015

Volltextzugriff (PDF)

3072 Phase 2: Docetaxel with or without ramucirumab as therapy for non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) activating mutations after prior EGFR tyrosine kinase inhibitor (TKI) and platinum-based chemotherapy

European journal of cancer (1990), 2015-09, Vol.51, p.S620-S620

2015

Volltextzugriff (PDF)

Fire performance, including the cooling phase, of structural glued laminated timber beams

Journal of structural fire engineering, 2016-01, Vol.7 (4), p.349-364

2016

Volltextzugriff (PDF)

Kinesiological evaluation after cTBS to contralesional motor cortex in restorative stage stroke patients

Journal of the neurological sciences, 2013-10, Vol.333, p.e251-e251

2013

Volltextzugriff (PDF)

Optimum site for cTBS in stroke-patients: A quantitative evaluation

Journal of the neurological sciences, 2013-10, Vol.333, p.e251-e251

2013

Volltextzugriff (PDF)

Effect of Topotecan as Second-Line Chemotherapy for Small Cell Lung Cancer Patients with Interstitial Lung Disease

Journal of chemotherapy (Florence), 2011-12, Vol.23 (6), p.367-370

2011

Volltextzugriff (PDF)

Strain difference of cadmium accumulation by liver slices of inbred Wistar-Imamichi and Fischer 344 rats

Toxicology in vitro, 2008-03, Vol.22 (2), p.338-343

2008

Volltextzugriff (PDF)

Prospective Study of Switch from Oral Medicine of Tramadolto Fentanyl Sticking Medicine in Thoracic Malignancy with the Pain

Annals of oncology, 2012-10, Vol.23, p.xi101

2012

Volltextzugriff (PDF)

Use of Hydrocolloids to Control Food Appearance, Flavor, Texture, and Nutrition

Amos Nussinovitch, Madoka Hirashima

1, 2023

Volltextzugriff (PDF)

1 – 25 von 5.462

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(3.518)
Mit Volltextzugriff
(4.386)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Electronic Journals Library
(2.870)
MEDLINE
(1.638)
Ingenta.com
(1.357)
Journals@Ovid Full Text
(870)
Elsevier ScienceDirect Journals Complete
(676)
Publisher or Other Site
(656)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(533)
Wiley Online Library
(493)
IngentaConnect Journals
(490)
SpringerLink_现刊
(370)
Wiley Online Library
(289)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(264)
Oxford Journals
(178)
Ebook Central Perpetual and DDA
(101)
eBooks on EBSCOhost
(101)
Nature_系列刊
(99)
IEL
(93)
Taylor & Francis Journals Complete
(87)
Oxford Journals 2020 Medicine
(72)
Taylor & Francis Journals
(70)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Final overall survival results of WJTOG3405, a randomized phase III trial comparing gefitinib versus cisplatin with docetaxel as the first-line treatment for patients with stage IIIB/IV or postoperative recurrent EGFR mutation-positive non-small-cell lung cancer

Randomized phase III study of bevacizumab plus FOLFIRI and bevacizumab plus mFOLFOX6 as first-line treatment for patients with metastatic colorectal cancer (WJOG4407G)

A randomized, double-blind, placebo-controlled, phase III trial of erlotinib with or without a c-Met inhibitor tivantinib (ARQ 197) in Asian patients with previously treated stage IIIB/IV nonsquamous nonsmall-cell lung cancer harboring wild-type epidermal growth factor receptor (ATTENTION study)

Multicentre prospective phase II trial of gefitinib for advanced non-small cell lung cancer with epidermal growth factor receptor mutations: results of the West Japan Thoracic Oncology Group trial (WJTOG0403)

NUMERICAL ANALYSIS OF LOAD‐BEARING FIRE TEST FOR REINFORCED CONCRETE SLABS

The effect of CYP2C19 polymorphism on the safety, tolerability, and pharmacokinetics of tivantinib (ARQ 197): results from a phase I trial in advanced solid tumors

Efficacy and safety analysis according to histology for S-1 in combination with carboplatin as first-line chemotherapy in patients with advanced non-small-cell lung cancer: updated results of the West Japan Oncology Group LETS study

Which of afatinib and gefitinib/erlotinib is the better EGFR-TKI to be followed by osimertinib?

Investigation of learning environment for arithmetic word problems by problem posing as sentence integration in Indonesian language

Process-based Assignment-Setting Change for Support of Overcoming Bottlenecks in Learning by Problem-Posing in Arithmetic Word Problems

Dose escalation study of carboplatin–pemetrexed followed by maintenance pemetrexed for elderly patients with advanced nonsquamous nonsmall-cell lung cancer

CYP2C19 genotype-based phase I studies of a c-Met inhibitor tivantinib in combination with erlotinib, in advanced/metastatic non-small cell lung cancer

Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain

3078 Updated results and efficacy analysis according to epidermal growth factor receptor (EGFR) mutation subtypes and metastatic sites for the phase II trial of gefitinib in combination with carboplatin plus S1

1325 A phase II study of pemetrexed plus carboplatin followed by maintenance pemetrexed as first-line chemotherapy for elderly patients (75-years-old) with advanced non-squamous, non-small cell lung cancer

3083 AZD9291 activity in patients with EGFR-mutant advanced non-small cell lung cancer (NSCLC) and brain metastases: Data from Phase II studies

521 Phase II studies of Nivolumab in patients with Advanced Squamous (SQ) or Non-Squamous (NSQ) Non-Small Cell Lung Cancer (NSCLC)

3072 Phase 2: Docetaxel with or without ramucirumab as therapy for non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) activating mutations after prior EGFR tyrosine kinase inhibitor (TKI) and platinum-based chemotherapy

Fire performance, including the cooling phase, of structural glued laminated timber beams

Kinesiological evaluation after cTBS to contralesional motor cortex in restorative stage stroke patients

Optimum site for cTBS in stroke-patients: A quantitative evaluation

Effect of Topotecan as Second-Line Chemotherapy for Small Cell Lung Cancer Patients with Interstitial Lung Disease

Strain difference of cadmium accumulation by liver slices of inbred Wistar-Imamichi and Fischer 344 rats

Prospective Study of Switch from Oral Medicine of Tramadolto Fentanyl Sticking Medicine in Thoracic Malignancy with the Pain

Use of Hydrocolloids to Control Food Appearance, Flavor, Texture, and Nutrition

Suchergebnisse filtern